Tuberculosis (TB) Diagnostics Market Report

Europe Tuberculosis (TB) Diagnostics Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 15, 2019
  • PAGES：179
  • REPORT CODE：GMM322650
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Tuberculosis (TB) Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Tuberculosis (TB) Diagnostics Market Segmentations:

    By Player:

    • QIAGEN

    • Becton

    • bioMérieux Corporation

    • Dickinson and Company

    • F Hoffmann-La Roche Laboratories

    • Cepheid

    • Hain Lifescience GmbH

    • F. Hoffmann-La Roche AG

    • Abbott SA

    • Sanofi

    • Alere, Inc.

    • Danaher, Inc.

    By Type:

    • Detection of Latent Infection

    • Radiographic Method

    • Diagnostic Laboratory Methods

    • Cytokine Detection Assay

    • Detection of Drug Resistance

    • Nucleic Acid Testing

    • Other Methods

    By End-User:

    • Hospitals

    • Clinics

    • Reference Laboratories

    • Research Institutes and Academics

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Tuberculosis (TB) Diagnostics Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Latent Infection from 2014 to 2026

    • 1.3.2 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Radiographic Method from 2014 to 2026

    • 1.3.3 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Diagnostic Laboratory Methods from 2014 to 2026

    • 1.3.4 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Cytokine Detection Assay from 2014 to 2026

    • 1.3.5 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Drug Resistance from 2014 to 2026

    • 1.3.6 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Nucleic Acid Testing from 2014 to 2026

    • 1.3.7 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Other Methods from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Clinics from 2014 to 2026

    • 1.4.3 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Reference Laboratories from 2014 to 2026

    • 1.4.4 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Research Institutes and Academics from 2014 to 2026

    • 1.4.5 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Tuberculosis (TB) Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Tuberculosis (TB) Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Detection of Latent Infection

      • 3.4.2 Market Size and Growth Rate of Radiographic Method

      • 3.4.3 Market Size and Growth Rate of Diagnostic Laboratory Methods

      • 3.4.4 Market Size and Growth Rate of Cytokine Detection Assay

      • 3.4.5 Market Size and Growth Rate of Detection of Drug Resistance

      • 3.4.6 Market Size and Growth Rate of Nucleic Acid Testing

      • 3.4.7 Market Size and Growth Rate of Other Methods

    4 Segmentation of Tuberculosis (TB) Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Tuberculosis (TB) Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics for Hospitals

      • 4.4.2 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics for Clinics

      • 4.4.3 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics for Reference Laboratories

      • 4.4.4 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics for Research Institutes and Academics

      • 4.4.5 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Tuberculosis (TB) Diagnostics Production Analysis by Top Regions

    • 5.2 Europe Tuberculosis (TB) Diagnostics Consumption Analysis by Top Regions

    • 5.3 Europe Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.3 France Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    6 Product Circulation of Tuberculosis (TB) Diagnostics Market among Top Countries

    • 6.1 Top 5 Export Countries in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Tuberculosis (TB) Diagnostics Landscape Analysis

    • 7.1 Germany Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 7.2 Germany Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    8. UK Tuberculosis (TB) Diagnostics Landscape Analysis

    • 8.1 UK Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 8.2 UK Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    9. France Tuberculosis (TB) Diagnostics Landscape Analysis

    • 9.1 France Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 9.2 France Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    10. Italy Tuberculosis (TB) Diagnostics Landscape Analysis

    • 10.1 Italy Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 10.2 Italy Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    11. Spain Tuberculosis (TB) Diagnostics Landscape Analysis

    • 11.1 Spain Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 11.2 Spain Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    12. Poland Tuberculosis (TB) Diagnostics Landscape Analysis

    • 12.1 Poland Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 12.2 Poland Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    13. Russia Tuberculosis (TB) Diagnostics Landscape Analysis

    • 13.1 Russia Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 13.2 Russia Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    14. Switzerland Tuberculosis (TB) Diagnostics Landscape Analysis

    • 14.1 Switzerland Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 14.2 Switzerland Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    15. Turkey Tuberculosis (TB) Diagnostics Landscape Analysis

    • 15.1 Turkey Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 15.2 Turkey Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Landscape Analysis by Top Countries

      • 16.3.1 Denmark Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 16.3.2 Finland Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 16.3.3 Norway Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 16.3.4 Sweden Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 16.3.6 Iceland Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Landscape Analysis by Top Countries

      • 17.3.1 Belgium Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 17.3.2 Netherlands Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 17.3.3 Luxembourg Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Landscape Analysis by Top Countries

      • 18.3.1 Estonia Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 18.3.2 Latvia Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

      • 18.3.3 Lithuania Tuberculosis (TB) Diagnostics Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 QIAGEN

      • 19.1.1 QIAGEN Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Becton

      • 19.2.1 Becton Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 bioMérieux Corporation

      • 19.3.1 bioMérieux Corporation Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Dickinson and Company

      • 19.4.1 Dickinson and Company Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 F Hoffmann-La Roche Laboratories

      • 19.5.1 F Hoffmann-La Roche Laboratories Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Cepheid

      • 19.6.1 Cepheid Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Hain Lifescience GmbH

      • 19.7.1 Hain Lifescience GmbH Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 F. Hoffmann-La Roche AG

      • 19.8.1 F. Hoffmann-La Roche AG Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Abbott SA

      • 19.9.1 Abbott SA Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Sanofi

      • 19.10.1 Sanofi Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Alere, Inc.

      • 19.11.1 Alere, Inc. Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Danaher, Inc.

      • 19.12.1 Danaher, Inc. Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 113 Figures and 117 Tables)

    • Figure Product Picture

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Latent Infection from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Radiographic Method from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Diagnostic Laboratory Methods from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Cytokine Detection Assay from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Drug Resistance from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Nucleic Acid Testing from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Other Methods from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Reference Laboratories from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Research Institutes and Academics from 2014 to 2026

    • Figure Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure UK Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure France Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Tuberculosis (TB) Diagnostics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Tuberculosis (TB) Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Tuberculosis (TB) Diagnostics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Tuberculosis (TB) Diagnostics by Different Types from 2014 to 2026

    • Table Consumption Share of Tuberculosis (TB) Diagnostics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Detection of Latent Infection

    • Figure Market Size and Growth Rate of Radiographic Method

    • Figure Market Size and Growth Rate of Diagnostic Laboratory Methods

    • Figure Market Size and Growth Rate of Cytokine Detection Assay

    • Figure Market Size and Growth Rate of Detection of Drug Resistance

    • Figure Market Size and Growth Rate of Nucleic Acid Testing

    • Figure Market Size and Growth Rate of Other Methods

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Tuberculosis (TB) Diagnostics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Tuberculosis (TB) Diagnostics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Reference Laboratories

    • Figure Market Size and Growth Rate of Research Institutes and Academics

    • Figure Market Size and Growth Rate of Others

    • Table Europe Tuberculosis (TB) Diagnostics Production by Major Regions

    • Table Europe Tuberculosis (TB) Diagnostics Production Share by Major Regions

    • Figure Europe Tuberculosis (TB) Diagnostics Production Share by Major Countries and Regions in 2014

    • Table Europe Tuberculosis (TB) Diagnostics Consumption by Major Regions

    • Table Europe Tuberculosis (TB) Diagnostics Consumption Share by Major Regions

    • Table Germany Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table UK Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table France Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Italy Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Spain Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Poland Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Russia Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Switzerland Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Turkey Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Tuberculosis (TB) Diagnostics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Germany Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Germany Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Germany Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table UK Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table UK Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table UK Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table UK Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table France Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table France Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table France Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table France Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Italy Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Italy Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Italy Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Italy Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Spain Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Spain Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Spain Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Spain Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Poland Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Poland Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Poland Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Poland Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Russia Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Russia Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Russia Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Russia Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Switzerland Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Switzerland Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Switzerland Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Turkey Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Turkey Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Turkey Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis (TB) Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis (TB) Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis (TB) Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Tuberculosis (TB) Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of Becton

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton

    • Figure Sales and Growth Rate Analysis of Becton

    • Figure Revenue and Market Share Analysis of Becton

    • Table Product and Service Introduction of Becton

    • Table Company Profile and Development Status of bioMérieux Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of bioMérieux Corporation

    • Figure Sales and Growth Rate Analysis of bioMérieux Corporation

    • Figure Revenue and Market Share Analysis of bioMérieux Corporation

    • Table Product and Service Introduction of bioMérieux Corporation

    • Table Company Profile and Development Status of Dickinson and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dickinson and Company

    • Figure Sales and Growth Rate Analysis of Dickinson and Company

    • Figure Revenue and Market Share Analysis of Dickinson and Company

    • Table Product and Service Introduction of Dickinson and Company

    • Table Company Profile and Development Status of F Hoffmann-La Roche Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Laboratories

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Laboratories

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Laboratories

    • Table Product and Service Introduction of F Hoffmann-La Roche Laboratories

    • Table Company Profile and Development Status of Cepheid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid

    • Figure Sales and Growth Rate Analysis of Cepheid

    • Figure Revenue and Market Share Analysis of Cepheid

    • Table Product and Service Introduction of Cepheid

    • Table Company Profile and Development Status of Hain Lifescience GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hain Lifescience GmbH

    • Figure Sales and Growth Rate Analysis of Hain Lifescience GmbH

    • Figure Revenue and Market Share Analysis of Hain Lifescience GmbH

    • Table Product and Service Introduction of Hain Lifescience GmbH

    • Table Company Profile and Development Status of F. Hoffmann-La Roche AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche AG

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche AG

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche AG

    • Table Product and Service Introduction of F. Hoffmann-La Roche AG

    • Table Company Profile and Development Status of Abbott SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott SA

    • Figure Sales and Growth Rate Analysis of Abbott SA

    • Figure Revenue and Market Share Analysis of Abbott SA

    • Table Product and Service Introduction of Abbott SA

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Alere, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere, Inc.

    • Figure Sales and Growth Rate Analysis of Alere, Inc.

    • Figure Revenue and Market Share Analysis of Alere, Inc.

    • Table Product and Service Introduction of Alere, Inc.

    • Table Company Profile and Development Status of Danaher, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher, Inc.

    • Figure Sales and Growth Rate Analysis of Danaher, Inc.

    • Figure Revenue and Market Share Analysis of Danaher, Inc.

    • Table Product and Service Introduction of Danaher, Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US